Skip to main content

Table 2 Current and estimated study size in the randomised screening design for cervical cancer, Finnish programme during 1999–2008.

From: Alternative technologies in cervical cancer screening: a randomised evaluation trial

  1999–2005 Overall 1999–2008
  Invited women Attended (estimate) Invited (estimate) Attended (estimate)
Randomised 862,800 609,100 1,000,000 706,000
Automation-assisted 262,900 185,300 301,900 212,800
HPV-DNA 50,800 35,600 99,600 70,000
Conventional 549,100 388,200 598,500 423,200